141 related articles for article (PubMed ID: 36494242)
1. Developing bespoke antimicrobials to combat antimicrobial resistance in low- and middle-income countries: A critical appraisal of clinical utility in the elderly.
MohanaSundaram A; Sathanantham ST; Sah R; Apostolopoulos V
Maturitas; 2023 Apr; 170():74-75. PubMed ID: 36494242
[No Abstract] [Full Text] [Related]
2. How Should We Manage Antimicrobial Resistance in Resource-Limited Settings?
Gulleen EA; Lubwama M
AMA J Ethics; 2024 May; 26(5):E373-379. PubMed ID: 38700521
[TBL] [Abstract][Full Text] [Related]
3. Menace of antimicrobial resistance in LMICs: Current surveillance practices and control measures to tackle hostility.
Sharma A; Singh A; Dar MA; Kaur RJ; Charan J; Iskandar K; Haque M; Murti K; Ravichandiran V; Dhingra S
J Infect Public Health; 2022 Feb; 15(2):172-181. PubMed ID: 34972026
[TBL] [Abstract][Full Text] [Related]
4. Use of Social Media as a Tool to Reduce Antibiotic Usage: A Neglected Approach to Combat Antimicrobial Resistance in Low and Middle Income Countries.
Acharya KP; Subedi D
Front Public Health; 2020; 8():558576. PubMed ID: 33363074
[No Abstract] [Full Text] [Related]
5. Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis.
Alsan M; Schoemaker L; Eggleston K; Kammili N; Kolli P; Bhattacharya J
Lancet Infect Dis; 2015 Oct; 15(10):1203-1210. PubMed ID: 26164481
[TBL] [Abstract][Full Text] [Related]
6. Interventions to address antimicrobial resistance: an ethical analysis of key tensions and how they apply in low- income and middle-income countries.
Pokharel S; Adhikari B; Johnson T; Cheah PY
BMJ Glob Health; 2024 Apr; 9(4):. PubMed ID: 38569658
[TBL] [Abstract][Full Text] [Related]
7. BSAC Vanguard Series: AMR diagnostics in light of evolving technologies and access in low- and middle-income countries.
Berman D; Neale R
J Antimicrob Chemother; 2021 Dec; 77(1):3-4. PubMed ID: 34791279
[TBL] [Abstract][Full Text] [Related]
8. Post COVID Antimicrobial Resistance Threat in Lower- and Middle-Income Countries: Bangladesh.
Mahadi AR
Front Public Health; 2021; 9():770593. PubMed ID: 34976929
[No Abstract] [Full Text] [Related]
9. Hospital-Based Antimicrobial Stewardship Programs Used in Low- and Middle-Income Countries: A Scoping Review.
Setiawan E; Abdul-Aziz MH; Roberts JA; Cotta MO
Microb Drug Resist; 2022 May; 28(5):566-584. PubMed ID: 35333607
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance in low- and middle-income countries: current status and future directions.
Sulis G; Sayood S; Gandra S
Expert Rev Anti Infect Ther; 2022 Feb; 20(2):147-160. PubMed ID: 34225545
[TBL] [Abstract][Full Text] [Related]
11. Global access to existing and future antimicrobials and diagnostics: antimicrobial subscription and pooled procurement.
Berman D; Chandy SJ; Cansdell O; Moodley K; Veeraraghavan B; Essack SY
Lancet Glob Health; 2022 Feb; 10(2):e293-e297. PubMed ID: 34914900
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial Resistance: a One Health Perspective.
McEwen SA; Collignon PJ
Microbiol Spectr; 2018 Mar; 6(2):. PubMed ID: 29600770
[TBL] [Abstract][Full Text] [Related]
13. Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future.
Godman B; Haque M; McKimm J; Abu Bakar M; Sneddon J; Wale J; Campbell S; Martin AP; Hoxha I; Abilova V; Anand Paramadhas BD; Mpinda-Joseph P; Matome M; de Lemos LLP; Sefah I; Kurdi A; Opanga S; Jakupi A; Saleem Z; Hassali MA; Kibuule D; Fadare J; Bochenek T; Rothe C; Furst J; Markovic-Pekovic V; Bojanić L; Schellack N; Meyer JC; Matsebula Z; Phuong TNT; Thanh BN; Jan S; Kalungia A; Mtapuri-Zinyowera S; Sartelli M; Hill R
Curr Med Res Opin; 2020 Feb; 36(2):301-327. PubMed ID: 31794332
[No Abstract] [Full Text] [Related]
14. Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis.
Ayobami O; Brinkwirth S; Eckmanns T; Markwart R
Emerg Microbes Infect; 2022 Dec; 11(1):443-451. PubMed ID: 35034585
[TBL] [Abstract][Full Text] [Related]
15. Plant synthetic biology for producing potent phyto-antimicrobials to combat antimicrobial resistance.
Tiwari P; Khare T; Shriram V; Bae H; Kumar V
Biotechnol Adv; 2021; 48():107729. PubMed ID: 33705914
[TBL] [Abstract][Full Text] [Related]
16. Using 'smart regulation' to tackle antimicrobial resistance in low-income and middle-income countries.
Porter G; Joshi J; Bhullar L; Kotwani A;
BMJ Glob Health; 2020; 5(1):e001864. PubMed ID: 32133168
[No Abstract] [Full Text] [Related]
17. Global trends in antimicrobial resistance in animals in low- and middle-income countries.
Van Boeckel TP; Pires J; Silvester R; Zhao C; Song J; Criscuolo NG; Gilbert M; Bonhoeffer S; Laxminarayan R
Science; 2019 Sep; 365(6459):. PubMed ID: 31604207
[TBL] [Abstract][Full Text] [Related]
18. Novel strategies for prevention and treatment of antimicrobial resistance in sexually-transmitted infections.
Williams E; Fairley CK; Williamson D
Curr Opin Infect Dis; 2021 Dec; 34(6):591-598. PubMed ID: 34545855
[TBL] [Abstract][Full Text] [Related]
19. Bacterial Resistance in Surgical Infections in Low-Resource Settings.
Rickard J
Surg Infect (Larchmt); 2020 Aug; 21(6):509-515. PubMed ID: 32380936
[No Abstract] [Full Text] [Related]
20. Neisseria gonorrhoeae Antimicrobial Resistance: Past to Present to Future.
Aitolo GL; Adeyemi OS; Afolabi BL; Owolabi AO
Curr Microbiol; 2021 Mar; 78(3):867-878. PubMed ID: 33528603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
